P848: TINOSTAMUSTINE (EDO-S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA

• A. Diaz-Tejedor,
• L. San-Segundo,
• L. A. Corchete,
• L. González-Méndez,
• M. Martín-Sánchez,
• M. Lorenzo-Mohamed,
• M. González-Rodríguez,
• M. Cruz-Hernández,
• M. Sánchez-Blázquez,
• N. C. Gutiérrez,
• M.-V. Mateos,
• M. Garayoa,
• E. M. Ocio,
• T. Paíno

Affiliations

A. Diaz-Tejedor

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

L. San-Segundo

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

L. A. Corchete

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

L. González-Méndez

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. Martín-Sánchez

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. Lorenzo-Mohamed

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. González-Rodríguez

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. Cruz-Hernández

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. Sánchez-Blázquez

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

N. C. Gutiérrez

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M.-V. Mateos

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

M. Garayoa

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca

E. M. Ocio

2 Department of Hematology, University Hospital Marques de Valdecilla (IDIVAL); University of Cantabria, Santander, Spain

T. Paíno

1 Department of Hematology, Cancer Research Center-IBMCC; University Hospital of Salamanca-IBSAL, Salamanca